The global in-vitro diagnostics quality control market is prognosticated to grow notably in forthcoming
years. Some of the major organizations in the global in vitro diagnostics quality control market comprise
of names, for example, Sysmex Corporation, Quantimetrix Corporation, Thermo Fisher Scientific Inc.,
Siemens Healthineers, Sun Diagnostics LLC, Seracare Life Sciences Inc., Randox Laboratories, Roche
Diagnostics, Ortho Clinical Diagnostics Inc., Bio-Rad Laboratories, Helena Laboratories, Abbott
Laboratories, and others. These firms are consistently working to achieve an edge over its competitors.
As a result, they are indulging into strategic activities in business, like tie-ups, mergers and acquisitions to
improve their entire market presence.
Request Brochure of Report -
According to Transparency market Research (TMR), the global market for in vitro diagnostics quality
control is anticipated to expand at a CAGR of 3.3% within the forecast period from 2017 to 2022. In 2017,
the market was valued around worth of US$710.8 mn. Owing to the further growth, the market is
anticipated to grow around worth of US$837 by the end of 2022.
On the basis of product type, the in vitro diagnostics quality control market is segmented into
serum/plasma based controls, whole blood based controls, urine based controls, quality assurance
services, data management solutions, and so on. Among these, whole blood based controls segment is
foreseen to lead the global market in forthcoming years, owing to comprehensive assessment property in
in vitro diagnostics. Geographically, North America region dominated the global in vitro diagnostics quality
controls market, with 37% of entire market, in 2017. The market is expected to grow around worth of
US$311.7 mn by the end of forecast period.
Request for Analysis of COVID-19 Impact on In Vitro Diagnostics Quality Control Market -